135 related articles for article (PubMed ID: 37725855)
1. DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities.
Zhao N; Zhang Z; Wang Q; Li L; Wei Z; Chen H; Zhou M; Liu Z; Su J
EBioMedicine; 2023 Oct; 96():104801. PubMed ID: 37725855
[TBL] [Abstract][Full Text] [Related]
2. The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma.
Yuan H; Qing T; Zhu S; Yang X; Wu W; Xu K; Chen H; Jiang Y; Zhu C; Yuan Z; Zhang T; Jin L; Suo C; Lu M; Chen X; Ye W
Cancer Med; 2023 Apr; 12(8):10077-10090. PubMed ID: 36708047
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair-associated signature.
Zhang P; Wen B; Gong J; Liu Z; Zhang M; Zhou G; Zhang L; Zhang Z
Environ Toxicol; 2024 May; 39(5):2803-2816. PubMed ID: 38287713
[TBL] [Abstract][Full Text] [Related]
4. Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma.
Guo JC; Lin CC; Hsu CL; Huang TC; Kuo HY; Lin CY; Lien MY; Cheng AL; Hsu CH
Esophagus; 2022 Oct; 19(4):693-701. PubMed ID: 35816242
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
6. DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.
Meng X; Duan C; Pang H; Chen Q; Han B; Zha C; Dinislam M; Wu P; Li Z; Zhao S; Wang R; Lin L; Jiang C; Cai J
EBioMedicine; 2019 Mar; 41():185-199. PubMed ID: 30773478
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
[No Abstract] [Full Text] [Related]
8. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Chen Z; Zhao M; Liang J; Hu Z; Huang Y; Li M; Pang Y; Lu T; Sui Q; Zhan C; Lin M; Guo W; Wang Q; Tan L
EBioMedicine; 2021 Jul; 69():103459. PubMed ID: 34192657
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features.
Maimaiti A; Liu Y; Abulaiti A; Wang X; Feng Z; Wang J; Mijiti M; Turhon M; Alimu N; Wang Y; Liang W; Jiang L; Pei Y
J Mol Neurosci; 2023 May; 73(4-5):269-286. PubMed ID: 37067735
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma.
Chen G; Zhu YJ; Chen J; Miao F; Wu N; Song Y; Mao BB; Wang SZ; Xu F; Chen ZM
Neoplasma; 2022 Dec; 69(6):1314-1321. PubMed ID: 36264776
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment.
Gao J; Tang T; Zhang B; Li G
Front Oncol; 2021; 11():603634. PubMed ID: 33718151
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy.
Zheng Y; Gao Q; Su X; Xiao C; Yu B; Huang S; Sun Y; Wu S; Wo Y; Xu Q; Xu N; Yu H
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291754
[TBL] [Abstract][Full Text] [Related]
15. Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.
Ko KP; Zhang S; Huang Y; Kim B; Zou G; Jun S; Zhang J; Martin C; Dunbar KJ; Efe G; Rustgi AK; Zhang H; Nakagawa H; Park JI
bioRxiv; 2023 Feb; ():. PubMed ID: 36824935
[TBL] [Abstract][Full Text] [Related]
16. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
Front Immunol; 2022; 13():918154. PubMed ID: 35880180
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.
Zhang Z; Chen L; Chen H; Zhao J; Li K; Sun J; Zhou M
EBioMedicine; 2022 Sep; 83():104207. PubMed ID: 35961204
[TBL] [Abstract][Full Text] [Related]
19. Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing.
Shi K; Li Y; Yang L; Zhang Z; Guo D; Zhang J; Lu Y
FASEB J; 2022 Nov; 36(11):e22620. PubMed ID: 36260317
[TBL] [Abstract][Full Text] [Related]
20. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]